Great post like always. Let's say Ipix is going it alone on B-OM. Mgmt takes money from the IBD deal and uses it in part to finance phase 3 for B-OM. Everything works fine and FDA grants the New Drug Application for sales and marketing of B-OM.

My question: in this scenario is the most likely option that Ipix is actually marketing and distributing B-OM all by itself?

Or is it also possible to get B-OM all alone to NDA status, but then partner with a global pharma company just to market and distribute the product? With their established sales channels to docs and patients in general this sounds like a feasible option with no overhead.

Is it an option to bring global pharma just on board for marketing and distribution? How much would such a partner charge in sales % for that?

I'm sorry I don't know much about sales channels, but would like to know more about who gets what cut for what service in the sales and distribution channel.